Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Sharps Technology Inc. STSS shares are trading higher Thursday after the company signed a $30 million purchase order from Nephron Pharmaceuticals. Sharps said the purchase order represents the first ...

Add Yahoo as a preferred source to see more of our stories on Google. Over 1,000 cases of streptococcal toxic shock syndrome (STSS) were reported in Japan in the first six months of 2024. The disease ...

Streptococcal Toxic Shock Syndrome (STSS) is a rare but serious bacterial infection that can progress rapidly and cause severe complications. It is primarily caused by certain strains of bacteria from ...

You would think the U.S. Missile Defense Agency (MDA), having spent upward of $1 billion to refurbish and launch a pair of missile-tracking demonstration satellites left over from a canceled program, ...

A rare, deadly, flesh-eating bacteria is on the rise in Japan, with hundreds of people infected. Over 1,000 cases of streptococcal toxic shock syndrome (STSS) were reported in Japan in the first six ...

Sharps Technology Inc. Annual cash flow by MarketWatch. View STSS net cash flow, operating cash flow, operating expenses and cash dividends.